Webinar Sponsored by Thermo Fisher Scientific Addresses Advancements in Oncology Research Using the Power of Multiplexing and Applications of the QuantiGene Plex Assay
YORBA LINDA, CA (PRWEB) November 06, 2017 -- Cancer research diagnostic services in pathology laboratories worldwide have been negatively impacted by a lack of fresh-frozen tissue samples, the degradation of DNA and RNA in archival tissue, and tumor heterogeneity. To achieve accurate and reproducible gene expression and amplification results using archival material, a more precise test that adapts to current clinical research workflows is needed.
Thermo Fisher Scientific, the world leader in serving science, has developed a comprehensive portfolio of Invitrogen immunoassays based on Luminex xMAP (multianalyte profiling) technology, a high-throughput solution enabling simultaneous detection and quantitation of multiple proteins.
Presented as part of the Protein and Cell Analysis Education Series Virtual Event, this webinar will discuss the benefits of multiplexing and Luminex technologies, as well as the use of QuantiGene Plex Assays to accurately measure RNA from archival tumor sections. Participants will have the opportunity to engage in a Q&A session with the experts.
The speaker for this event will be Dr. Godfrey Grech, head of the Laboratory of Molecular Pathology at the University of Malta.
Grech is an associate professor at the University of Malta and currently responsible for the Molecular Pathology Research Laboratory and Director of Biotech Innovations, a spin-off company. The main research topic aims to identify biomarkers to classify breast cancer patients into a specific therapeutic group that shall benefit from activation of phosphatases as a main therapeutic option.
LabRoots will host the webinar on November 7, 2017, beginning at 8 a.m. PST. To learn more about this event, discover the continuing education credits that will be offered, or to register for free, click here.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit http://www.thermofisher.com.
About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.
Karen Sorenson, LabRoots, Inc., http://www.LabRoots.com, +1 (619) 861-0590, [email protected]
Share this article